Difficulty: Medium
Average Score: 90%
Practice
In Langerhans cell histiocytosis (LCH), which organ is LEAST likely affected?
Correct answer
E
Rationale
In Langerhans cell histiocytosis (LCH), the organ that is LEAST likely affected is the ear. LCH is a rare disorder characterized by the overproduction of Langerhans cells in the body. These cells can infiltrate various organs and tissues, causing a range of symptoms.
The skin is commonly affected in LCH, presenting as rashes, papules, or nodules. Bones are another commonly affected site, leading to bone pain, fractures, and deformities. Involvement of lymph nodes, especially the mediastinal lymph nodes, is also common in LCH.
The ear, however, is less frequently affected in LCH compared to the skin, bones, and lymph nodes. While it is still possible for Langerhans cells to infiltrate the ear and cause symptoms such as otitis externa or otitis media, it is relatively less common compared to other organs.
Educationally, understanding the typical organ involvement in LCH is crucial for healthcare professionals caring for pediatric patients. Recognizing the pattern of organ involvement can aid in early diagnosis and appropriate management of this condition, improving patient outcomes.
The skin is commonly affected in LCH, presenting as rashes, papules, or nodules. Bones are another commonly affected site, leading to bone pain, fractures, and deformities. Involvement of lymph nodes, especially the mediastinal lymph nodes, is also common in LCH.
The ear, however, is less frequently affected in LCH compared to the skin, bones, and lymph nodes. While it is still possible for Langerhans cells to infiltrate the ear and cause symptoms such as otitis externa or otitis media, it is relatively less common compared to other organs.
Educationally, understanding the typical organ involvement in LCH is crucial for healthcare professionals caring for pediatric patients. Recognizing the pattern of organ involvement can aid in early diagnosis and appropriate management of this condition, improving patient outcomes.